Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction? - Related Studies

Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?

This study is currently recruiting participants.

Study NCT00688480. Last updated on July 10, 2008. Information provided by University of Dundee

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Kidney Disease
		Left Ventricular Hypertrophy

2	Additional conditions recognized in this trial
		Hypertrophy
		Hypertrophy, Left Ventricular
		Kidney Diseases

3	More general conditions related to this trial
		Cardiomegaly
		Cardiovascular Diseases
		Heart Diseases
		Pathological Conditions, Anatomical
		Urologic Diseases

4	Interventions listed in this trial
		Placebo
		Allopurinol

5	More general drug interventions related to this trial
		Antimetabolites
		Antioxidants
		Antirheumatic Agents
		Enzyme Inhibitors
		Free Radical Scavengers
		Gout Suppressants
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protective Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		University of Dundee